High CD8+ TRM cell numbers have been correlated with better patient prognosis in HPV+OPSCC compared to their peripheral counterparts (243) and have shown to be a good prognostic indicator in many other malignancies including melanoma, ovarian and cervical cancer (333). This evidence concerns the gene CD8A and melanoma.